Bronchoscopy Market

The increasing prevalence of respiratory disease is propelling the market growth of bronchoscopy. The increasing prevalence of respiratory disease such as lung cancer, asthma, chronic obstructive pulmonary disease (COPD). In addition, rising demand for advanced therapeutics further boosts the growth of this market. For Instance, in 2020, as per the World Cancer Research Fund International lung cancer is the second most common cancer across the globe. It is the most common cancer in men and second most common cancer in women. There were more than 2.2 million new cases of lung cancer reported in 2020.

The ten countries including Hungary, Serbia, France, Turkey, Montenegro, Belgium, Bosnia and Herzegovina, and Denmark are the highest number of deaths from lung cancer in 2020. Moreover in 2020, around 545 million patients will live with a chronic respiratory condition which represents 7.4% of world population which increasing burden on healthcare sector as well as directly influence the market demand of bronchoscopy.

The Global Bronchoscopy Market Industry is on a trajectory of robust growth, with projections indicating a market value of 2.8 USD Billion in 2024 and an anticipated increase to 5.91 USD Billion by 2035. This growth reflects a compound annual growth rate (CAGR) of 7.03% from 2025 to 2035. Factors contributing to this expansion include technological advancements, rising prevalence of respiratory diseases, and increased healthcare spending. As the market evolves, it is essential to monitor these trends to understand the dynamics shaping the future of bronchoscopy.

The Global Bronchoscopy Market Industry benefits from increasing awareness and education regarding respiratory health. Public health campaigns and educational programs are essential in informing patients and healthcare providers about the importance of early diagnosis and treatment of respiratory conditions. This heightened awareness leads to an increase in the number of patients seeking bronchoscopy procedures. Furthermore, healthcare professionals are receiving enhanced training in bronchoscopy techniques, which may improve procedural outcomes. As awareness continues to rise, the market is likely to expand, contributing to the projected growth to 2.8 USD Billion in 2024.

The aging population is a significant driver of the Global Bronchoscopy Market Industry. As individuals age, the incidence of respiratory diseases tends to increase, necessitating more frequent bronchoscopy procedures for diagnosis and treatment. The World Health Organization reports that the global population aged 65 and older is projected to reach 1.5 billion by 2050. This demographic shift is likely to create a sustained demand for bronchoscopy services, as older adults often present with complex health issues. Consequently, the market is expected to witness a compound annual growth rate (CAGR) of 7.03% from 2025 to 2035, reflecting the growing healthcare needs of this population.

Government initiatives aimed at improving healthcare infrastructure significantly influence the Global Bronchoscopy Market Industry. Many countries are investing in healthcare systems to enhance access to diagnostic and therapeutic services. For instance, funding for respiratory health programs and the establishment of specialized centers for lung diseases are becoming more common. These initiatives not only facilitate the adoption of bronchoscopy procedures but also promote awareness about respiratory health. As governments prioritize respiratory disease management, the market is poised for growth, aligning with the projected increase in market value to 5.91 USD Billion by 2035.

The Global Bronchoscopy Market Industry experiences a notable surge due to the increasing prevalence of respiratory diseases such as chronic obstructive pulmonary disease (COPD) and lung cancer. According to health statistics, respiratory diseases are among the leading causes of morbidity and mortality worldwide. This trend necessitates advanced diagnostic and therapeutic interventions, propelling the demand for bronchoscopy procedures. In 2024, the market is projected to reach 2.8 USD Billion, reflecting the urgent need for effective management of these conditions. As awareness grows and healthcare systems adapt, the Global Bronchoscopy Market Industry is likely to expand significantly.

Technological innovations play a pivotal role in shaping the Global Bronchoscopy Market Industry. The introduction of advanced imaging techniques, such as high-definition video bronchoscopy and navigational bronchoscopy, enhances the precision of procedures. These advancements not only improve diagnostic accuracy but also reduce procedural complications. Furthermore, the integration of artificial intelligence in bronchoscopy aids in real-time decision-making, potentially leading to better patient outcomes. As these technologies become more widely adopted, the market is expected to grow, with projections indicating a rise to 5.91 USD Billion by 2035, underscoring the importance of innovation in healthcare.

By Region, the study segments the market into North America, Europe, Asia-Pacific, and the Rest of the World. The North America bronchoscopy market accounted for USD 1.5 billion in 2021 and is expected to exhibit a 5.2% CAGR during the study period. This is attributed to the presence of key players, high prevalence rate of lung cancer, increasing cases of COPD disease in US, availability of advance treatment is further boosting the market growth of bronchoscopy in North America.

For instance: In 2021 more than 25 million patients in US suffered from asthma as well as more than 16 million people in the US had COPD (chronic obstructive pulmonary disease), which is cause of death. Moreover, the American Cancer Society in 2023 approximate 238,340 new cases of lung cancer as well as 127,070 deaths from lung cancer reported in US. Thus, increasing prevalence of lung cancer, rising new cases of asthma, and the presence of major key players is further boosting the market growth in North America.

As per the Canadian Cancer Society approximate 30,000 Canadians was diagnosed with lung cancer and bronchus cancer. This indicates 13% of all new cancer cases in 2022.

Further, the major countries studied are the U.S., Canada, Germany, France, the UK, Italy, Spain, China, Japan, India, Australia, South Korea, and Brazil.

Figure 3: BRONCHOSCOPY MARKET SHARE BY REGION, 2021 & 2030 (USD BILLION)

Europe bronchoscopy market is expected to account for the second-largest market share due to increasing investment in healthcare expenditure, technological advancements, increasing advancement in bronchoscopy, a rising regulatory approval for bronchoscope portfolio. For instance: In May 2021, Pantax Medical Europe received CE mark for its single use bronchoscope PulmoONE. This advanced technological product offers high quality care with advanced care in pulmonary care. The PulmoONE is a single use bronchoscope with advance power and HD image quality. Thus, rising product approval, technological developments, rising healthcare expenditure are further boosting the market growth of bronchoscopy in Europe region.

The Asia-Pacific bronchoscopy market is expected to fastest be growing from 2022 to 2030. This Asia-Pacific is expected to grow at the fastest CAGR of 7.0% during the forecast period. Rising research and development activity, easy availability of labour cost, growing use of advance bronchoscopy technology use in hospitals, increasing statergic alliance such as merger, acquisition, agreement, and collaboration are rising market scope of bronchoscopy in Asia-Pacific region. For instance: In March 2023, Yashoda Hospitals in India, and Asia to utilize advance diagnostic bronchoscopy technology with LungVision AI driven intraoperative CT imaging.

Thus, rising strategic decision by key players, highly investment major key players for research and development activity are drive the market growth of bronchoscopy in Asia-Pacific region.

The rest of the world is comprised of the Middle East, Africa, and Latin America. This segment is projected to hold the least market share. In this region, the Middle East is anticipated to dominate due to the improving medical facility, growing investment in healthcare infrastructure, rising consumption of tobacco leads to the risk of lung cancer which is directly influence the market demand of bronchoscopy in the Rest of the World.

The Bronchoscopy Market is characterized by the presence of many global, regional, and local vendors catering to the demand created by medical devices and research scientists operating in the industry. The major players heavily invest in research and development activity across the globe with varied product portfolios.

Companies such as Olympus Corporation (Japan), Teleflex, Inc. (US), Ambu A/S (Denmark), Karl Storz GmbH (Germany), Fujifilm Holdings Corporation (Japan) dominate the Market of Bronchoscopy due to strong brand image, extensive business network across the globe, heavily investment in research and development activity, financial stability, statergic alliance, and wide business presence in across the globe. The key players are focused on the development of new products. Moreover, they adopt growth initiatives, such as collaboration, product launches, mergers, and acquisition, to strengthen their market position and gain a large customer base.

One of the primary business strategies adopted by manufacturers in the global bronchoscopy industry to benefit clients and expand the market sector is to manufacture locally to reduce operating costs. Olympus Corporation (Japan) is a global medical device company which is engage in development of optics and reprography products. The company distributes its products in more than 40 countries. The company holds around 17,000 patents as well as acquiring new technology to build up its business across the globe.

For instance: In May 2022, Olympus Corporation, a Japanese manufacturer of optics and reprography products signed a group purchasing agreement with Premier, Inc. in the Single-Use Visualization Devices category for their single-use bronchoscope portfolio.

Teleflex Incorporated (US) is a medical technology company which design and develop various healthcare products. The company product portfolio is diverse around emergency medicine, surgical, vascular access, interventional cardiology and radiology, anaesthesia, and respiratory care. It offers product under the segment of surgical, respiratory, interventional urology, and urology. The company operated its business in more than 150 countries.